Target intelligence / Profile preview

Immunoglobulin heavy variable 4-28 (IGHV4-28)

Target
IGHV4-28
Molecular classification
Variable region of immunoglobulin heavy chain, Immunoglobulin gene segment, antibody gene
01

Overview

Immunoglobulin heavy variable 4-28 (IGHV4-28) is a protein coding gene segment located within the immunoglobulin heavy-chain (IGH) locus on chromosome 14. This locus encodes the variable (V), diversity (D), joining (J), and constant (C) gene segments necessary for the biosynthesis of the antibody heavy chain, a key molecule of the adaptive immune system. The protein product of IGHV4-28 forms part of the variable region of antibody heavy chains, contributing to the antigen-binding site in combination with a light chain. This variable region is generated by V-(D)-J recombination and further diversified through somatic hypermutation, enabling broad antibody specificity and affinity maturation. In the recognition phase of humoral immunity, membrane-bound immunoglobulins containing IGHV4-28 act as B cell receptors that bind antigens and trigger B-cell clonal expansion and differentiation. IGHV4-28 gene usage may vary between individuals (allelic/polymorphic variation) and is involved in clonal expansions under pathological conditions, such as immune thrombocytopenia. However, IGHV4-28 itself is not a therapeutic target; instead, it is an essential genetic element for antibody diversity and effective immune responses.

Other names
IGHV4-28IGHV428HV428VHimmunoglobulin heavy chain variable regionImmunoglobulin Heavy Variable 4-28
02

Biological functions

Antigen recognitionImmunoglobulin mediated immune responseB cell receptor diversityHumoral immune responseAffinity maturation via somatic hypermutation
03

Disease associations

Immune dysregulation (e.g. abnormal clonal expansions in autoimmune disease like immune thrombocytopenia)Other (genetic polymorphisms in IGHV segments may influence susceptibility, antibody repertoire, or disease severity in immune-related conditions)
04

Safety considerations

No direct safety concerns, but aberrant clonal expansion of IGHV4-28-expressing B cells associated with autoimmunity or lymphoproliferative disorders
05

Biomarkers

IGHV4-28 usage pattern can sometimes be a biomarker for B cell clonality in disease, e.g. autoimmune diseases such as ITP

Beyond the preview

Go deeper on Immunoglobulin heavy variable 4-28 (IGHV4-28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 4-28 (IGHV4-28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call